Details

<p>List of Contributors, vii</p> <p>Preface, x</p> <p><b>Part I Prediabetes and the Diagnosis of Diabetes</b></p> <p>1 “Is Prediabetes a Risk Factor or Is It a Disease?” 3<br /> <i>Jacob Kohlenberg and Adrian Vella</i></p> <p>2 Early Diagnosis of Type 1 Diabetes – Useful or a Pyrrhic Victory? 17<br /> <i>Paolo Pozzilli and Silvia Pieralice</i></p> <p>3 Reclassifying or Declassifying Diabetes? Can Clinical Characteristics Guide Classification and<br /> Treatment? 37<br /> <i>Adrian Vella</i></p> <p>4 How Should Secondary Causes of Diabetes Be Excluded? 45<br /> <i>Tomás P. Griffin, Aonghus O’Loughlin, and Sean F.</i> <i>Dinneen</i></p> <p>5 How to Screen Appropriately for Monogenic Diabetes 68<br /> <i>Adrian Vella</i></p> <p><b>Part II Initial Evaluation and Management of Diabetes</b></p> <p>6 Managing Gestational Diabetes During and After Pregnancy 75<br /> <i>Aoife M. Egan and Fidelma P. Dunne</i></p> <p>7 What Is the Role of Self‐Monitoring in Diabetes? Is There a Role for Postprandial Glucose Monitoring? How Does Continuous Glucose Monitoring Integrate into Clinical Practice? 87<br /> <i>Rami Almokayyad and Robert Cuddihy</i></p> <p>8 Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes? 101<br /> <i>Kristen Gonzales and Steve A. Smith</i></p> <p>9 Technology Issues: Continuous Glucose Monitoring, Insulin Pumps, and Closed Loop Control for Patients with Diabetes 115<br /> <i>Ravinder Jeet Kaur, Shafaq R. Rizvi and Yogish C. Kudva</i></p> <p>10 Optimizing Diet in Patients with Diabetes 124<br /> <i>Meera Shah</i></p> <p>11 Are Insulin Sensitizers Useful Additions to Insulin Therapy? 133<br /> <i>John W. Richard, III and Philip Raskin</i></p> <p>12 Incretin‐Based Therapy for the Management of Type 2 Diabetes 146<br /> <i>Kristin Gonzales and Adrian Vella</i></p> <p><b>Part III Diagnosis and Management of Cardiovascular Risk Factors and Cardiovascular Disease</b></p> <p>13 Screening Patients with Prediabetes and Diabetes for Cardiovascular Disease 163<br /> <i>Sabreen Ahmed, Saritha Tirumalasetty and Vivian Fonseca</i></p> <p>14 Choosing Medications for Type 2 Diabetes – What Weighting Should Be Given to Cardiovascular Risk Reduction? 174<br /> <i>Adrian Vella</i></p> <p>15 Choosing Medications for Weight Loss in Type 2 Diabetes Mellitus 187<br /> <i>Shubhada Jagasia, Chase Dean Hendrickson and Alexander J. Williams</i></p> <p>16 Are Statins the Optimal Therapy for Cardiovascular Risk in Patients with Diabetes? What Newer Agents Are There for the Treatment for Dyslipidemia in Diabetes? Are Triglycerides an Important Risk Factor for Diabetes? 198<br /> <i>Recie Davern and Timothy O’Brien</i></p> <p>17 New Agents for Treatment of Dyslipidemia 211<br /> <i>Vinaya Simha</i></p> <p>18 The Role of Bariatric Surgery in Obese Patients with Diabetes: Primary or Rescue Therapy? 220<br /> <i>Praveena Gandikota and Blandine Laferrère</i></p> <p>19 Treatment Strategies in Patients with Diabetes Mellitus and Ischemic Heart Disease 228<br /> <i>Madeline K. Mahowald, Chiam Leker Locker, Mandeep</i> <i>Singh and Robert L. Frye</i></p> <p><b>Part IV Management of Disease Complications</b></p> <p>20 Diabetes Management in Patients with Critical and Non-Critical Illness 241<br /> <i>Kalpana Muthusamy, Kristin Grdinovac and John M. Miles</i></p> <p>21 Diagnosis and Management of Ophthalmic Complications of Diabetes 252<br /> <i>Andrew J. Barkmeier and Konstantin Astafurov</i></p> <p>22 Upper Gastrointestinal Manifestations of Diabetes 269<br /> <i>Michael Camilleri</i></p> <p>Index 280</p>

<p>Edited by</p> <p><b>Adrian Vella MD</b> is the Earl and Annette R. McDonough Professor of Medicine, and the Research Chair of the Division of Diabetes, Endocrinology & Metabolism in the Department of Medicine, Mayo Clinic College of Medicine, US

<p><b>Clinical Dilemmas in Diabetes</b></p> <p><i>Clinical Dilemmas in Diabetes</i> answers the clinical questions commonly encountered when diagnosing, treating, and managing patients with diabetes and its associated complications. Designed to support informed, evidence-based care, this authoritative clinical guide includes contributions from leading endocrinologists and diabetes researchers that discuss a diverse range of recent developments. Concise and focused chapters cover prediabetes, diabetes diagnosis, initial evaluation and management, disease complications, and cardiovascular disease and risk factors. <p>Now in its second edition, <i>Clinical Dilemmas in Diabetes</i> contains extensively reviewed and revised information throughout. New and updated chapters examine prediction, diagnosis, and management of early Type 1 diabetes, ophthalmic complications, screening asymptomatic patients for cardiovascular disease, new agents for treatment of dyslipidemia, closed loop systems in Type 1 diabetes, upper gastrointestinal manifestations, managing hyperglycemia in critically ill patients, and more. Edited by Dr. Vella at the Mayo Clinic, this highly practical resource: <ul><li>Encourages evidence-based clinical decision-making, rather than algorithm-based approaches </li> <li>Provides clear guidance on common problematic areas, especially in cases where conflicts in treatment for the disease and the complications occur</li> <li>Emphasizes the importance of translating the results of clinical trials to individual care and management of diabetes</li> <li>Contains effective learning and revision tools, including learning points, chapter introductions and summaries, tables, figures, charts, and full references</li></ul> <p>Part of the popular <i>Clinical Dilemmas series, Clinical Dilemmas in Diabetes </i>is a must-have guide for anyone involved in the treatment of patients with diabetes, particularly endocrinologists, diabetes specialists and consultants, cardiologists, residents, fellows, specialist nurses, and general practitioners with an interest in diabetes.

GB